Table 4.
HUVECs and AoSMC viability in the presence of polyurethane composites.
| PU | Starch | Concentration | HUVECs Viability (%) ** | AoSMC Viability (%) ** |
|---|---|---|---|---|
| Control | 100% | 100% | ||
| P1 | AL-0% | 82.23 ± 0.96 a | 106.59 ± 17.02 a | |
| AL-N | 1% | 88.28 ± 4.57 a | 99.73 ± 4.15 a | |
| 2% | 89.74 ± 2.74 a | 106.73 ± 3.08 a | ||
| 3% | 92.49 ± 3.09 a | 105.14 ± 4.72 a | ||
| AL-Z | 1% | 85.98 ± 4.00 a | 195.23 ± 22.38 b | |
| 2% | 83. 79 ± 9.29 a | 172.40 ± 37.82 b | ||
| 3% | 88.73 ± 2.48 a | 195.10 ± 14.20 b | ||
| p-values | ||||
| Starch | 0.107 | <0.001 * | ||
| Concentration | 0.031 * | 0.003 * | ||
| Starch/Concentration | 0.683 | 0.001 * | ||
| Control | 100% | 100% | ||
| P2 | AL-0% | 83.24 ± 3.96 a | 100.26 ± 2.39 a | |
| AL-N | 1% | 71.70 ± 21.26 ab | 105.80 ± 5.38 a | |
| 2% | 79.94 ± 11.29 a | 98.65 ± 16.79 a | ||
| 3% | 64.74 ± 12.67 ab | 83.72 ± 33.96 a | ||
| AL-Z | 1% | 37.91 ± 10.28 b | 169.49 ± 58.56 a | |
| 2% | 33.70 ± 11.82 b | 141.18 ± 18.07 a | ||
| 3% | 34.89 ± 22.37 b | 166.05 ± 46.96 a | ||
| p-values | ||||
| Starch | <0.001 * | 0.002 * | ||
| Concentration | 0.003 * | 0.239 | ||
| Starch/Concentration | 0.059 | 0.152 | ||
| Control | 100% | 100% | ||
| P3 | AL-0% | 77.01 ± 9.35 a | 81.79 ± 20.28 a | |
| AL-N | 1% | 77.93 ± 5.21 a | 78.13 ± 9.05 a | |
| 2% | 69.78 ± 11.13 ac | 75.03 ± 15.91 a | ||
| 3% | 79.12 ± 6.19 a | 71.68 ± 36.78 a | ||
| AL-Z | 1% | 35.44 ± 6.71 bc | 79.06 ± 43.76 a | |
| 2% | 40.11 ± 14.60 bc | 115.04 ± 54.41 a | ||
| 3% | 45.78 ± 7.41 c | 112.08 ± 22.78 a | ||
| p-values | ||||
| Starch | <0.001 * | 0.133 | ||
| Concentration | 0.003 * | 0.771 | ||
| Starch/Concentration | 0.006 * | 0.512 | ||
** Samples with the same letter are not statistically significantly different. However, samples with different letters have significant differences. * Effects are statistically significant (p-value < 0.05).